
1.34 Delayed Data As of Nov 28 | ![]() Today’s Change | 1.04 Today|||52-Week Range 3.02 | -16.25% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $91.1M |
CytomX Therapeutics, Inc. 151 Oyster Point Boulevard South San Francisco California 94080-1913 |
Sean A. McCarthy | Chairman, President & Chief Executive Officer |
Chris Ogden | Chief Financial & Accounting Officer |
Marcia P. Belvin | Chief Scientific Officer & Senior Vice President |
Yu Waye Chu | Chief Medical Officer |
Lloyd A. Rowland | Secretary, Compliance Officer & General Counsel |